May 22, 2026Effective9999999995-26-001752
All companies
Trade Synergy Chc Corp
SY
Synergy Chc Corp
SNYRPublicArchived
Public / ArchivedUnited States(Nasdaq)Best valuation $2.59M1 market
Public listing
Listed· Nasdaq· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: sec-harvest, nasdaq
IPO Calendar · NasdaqIPO
SNYRPrice
$0.1740
24h
-0.80%
Valuation
$2.59M
24h volume
$20.72K
Type
IPO
Trade Synergy Chc CorpNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 58m ago
Financials
UnprofitableFrom SEC filings, latest FY ending Dec 31, 2019 · CIK 0001562733.
Revenue · -13.21% YoY
$29.36M
Net income
-$12.34M
Gross margin
69.16%
Cash
$2.62M
| Metric | 2025 | 2024 | 2023 | 2022 | 2019 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | $29.36M |
| Gross profit | $20.3M | $23.64M | $32.08M | — | $20.22M |
| Operating income | -$8.46M | $5.8M | $10.81M | — | -$7.96M |
| Net income | -$12.34M | $2.12M | $6.34M | — | -$9.21M |
| Cash & equivalents | $2.62M | $687.92K | $632.53K | — | $1.22M |
| Total assets | $10.16M | $16.34M | $12.24M | — | $5.19M |
| Total liabilities | $33.29M | $32.97M | $39.55M | — | $10.39M |
| Shareholders' equity | -$23.13M | -$16.63M | -$27.31M | -$33.52M | -$5.2M |
About Synergy Chc Corp
Synergy Chc Corp is its current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically-tested brain health supplement (this study was performed independently and is not related to any U.S.
What the company does
- Food and Drug Administration ("FDA") -approved investigational new drug (IND) application) that has been shown to improve memory, concentration and focus, and Flat Tummy, a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight.
- Operates with a business profile defined by its products, services, customers, and operating execution.
- Its durable fundamentals depend on demand for its products or services, margin structure, competitive position, management execution, and capital discipline.
Business profile
Synergy Chc Corp should be evaluated through its durable business model: what it sells, who it serves, how it generates revenue, and how efficiently it can scale.
SEC IPO filings
EffectiveEDGAR filings resolved from SNYR / CIK 0001562733.
CORRESPfilename1.htm
May 21, 2026SEC correspondence0001213900-26-060036
UPLOADfilename1.pdf
May 21, 2026SEC correspondence0000000000-26-005198
May 15, 2026Filed0001213900-26-057939
Dec 9, 2025Effective9999999995-25-003617
CORRESPfilename1.htm
Dec 8, 2025SEC correspondence0001213900-25-119224
424B4PROSPECTUS
Aug 26, 2025Final prospectus0001213900-25-080764
Aug 25, 2025Effective9999999995-25-002739
CORRESPfilename1.htm
Aug 25, 2025SEC correspondence0001213900-25-080079
CORRESPfilename1.htm
Aug 25, 2025SEC correspondence0001213900-25-080078
Aug 15, 2025Filed0001213900-25-077458
UPLOADfilename1.pdf
May 8, 2025SEC correspondence0000000000-25-004916
Synergy Chc Corp IPO — frequently asked questions
- When did Synergy Chc Corp go public?
- Synergy Chc Corp has already gone public and now trades publicly on Nasdaq under the ticker SNYR.
- Can I buy Synergy Chc Corp stock?
- Yes — Synergy Chc Corp is publicly traded on Nasdaq as SNYR. You can follow its live price, valuation and post-IPO performance above.
- What is Synergy Chc Corp's valuation?
- Synergy Chc Corp's most recent valuation tracked here is $2.59M, derived from live market prices.